A threshold caloric test- results in normal subjects

Threshold caloric test on normal subjects - responses to hot and cold caloric stimulatio

Acoustic attenuation determined experimentally during engine ground tests of the XB-70 airplane and comparison with predictions

Acoustic attenuation determined experimentally during engine ground tests of XB-70 airplane and comparison with prediction

Variability in sonic-boom signatures measured along an 8000-foot linear array

Variability in sonic boom signatures measured along 8000 foot linear microphone arra

Fuzzy Human Reliability Analysis: Applications and Contributions Review

The applications and contributions of fuzzy set theory to human reliability analysis (HRA) are reassessed. The main contribution of fuzzy mathematics relies on its ability to represent vague information. Many HRA authors have made contributions developing new models, introducing fuzzy quantification methodologies. Conversely, others have drawn on fuzzy techniques or methodologies for quantifying already existing models. Fuzzy contributions improve HRA in five main aspects: (1) uncertainty treatment, (2) expert judgment data treatment, (3) fuzzy fault trees, (4) performance shaping factors, and (5) human behaviour model. Finally, recent fuzzy applications and new trends in fuzzy HRA are herein discussed

Stationary Kolmogorov Solutions of the Smoluchowski Aggregation Equation with a Source Term

In this paper we show how the method of Zakharov transformations may be used to analyze the stationary solutions of the Smoluchowski aggregation equation for arbitrary homogeneous kernel. The resulting massdistributions are of Kolmogorov type in the sense that they carry a constant flux of mass from small masses to large. We derive a ``locality criterion'', expressed in terms of the asymptotic properties of the kernel, that must be satisfied in order for the Kolmogorov spectrum to be an admissiblesolution. Whether a given kernel leads to a gelation transition or not can be determined by computing the mass capacity of the Kolmogorov spectrum. As an example, we compute the exact stationary state for the family of kernels,$K_\zeta(m_1,m_2)=(m_1m_2)^{\zeta/2}$ which includes both gelling and non-gelling cases, reproducing the known solution in the case $\zeta=0$. Surprisingly, the Kolmogorov constant is the same for all kernels in this family.Comment: This article is an expanded version of a talk given at IHP workshop "Dynamics, Growth and Singularities of Continuous Media", Paris July 2003. Updated 01/04/04. Revised version with additional discussion, references added, several typographical errors corrected. Revised version accepted for publication by Phys. Rev.

The effects of exposure to a rotating environment /10 rpm/ on four aviators for a period of twelve days

Motion sickness studies of aviators exposed to rotating environment - Aerospace medicin

Scientific Objectives of Einstein Telescope

The advanced interferometer network will herald a new era in observational astronomy. There is a very strong science case to go beyond the advanced detector network and build detectors that operate in a frequency range from 1 Hz-10 kHz, with sensitivity a factor ten better in amplitude. Such detectors will be able to probe a range of topics in nuclear physics, astronomy, cosmology and fundamental physics, providing insights into many unsolved problems in these areas.Comment: 18 pages, 4 figures, Plenary talk given at Amaldi Meeting, July 201

Correction: A european spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics (PLoS ONE (2016) 11:9 (e0162866) DOI: 10.1371/journal.pone.0162866)

The thirty-Third author's name is spelled incorrectly. The correct name is: Jadranka Sertić

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity with the underlying genetic composition, particularly in genes encoding for protein factors and enzymes involved in drug metabolism and transport. In several European populations, particularly in countries with lower income, information related to the prevalence of pharmacogenomic biomarkers is incomplete or lacking. Here, we have implemented the microattribution approach to assess the pharmacogenomic biomarkers allelic spectrum in 18 European populations, mostly from developing European countries, by analyzing 1,931 pharmacogenomics biomarkers in 231 genes. Our data show significant interpopulation pharmacogenomic biomarker allele frequency differences, particularly in 7 clinically actionable pharmacogenomic biomarkers in 7 European populations, affecting drug efficacy and/ or toxicity of 51 medication treatment modalities. These data also reflect on the differences observed in the prevalence of high-risk genotypes in these populations, as far as common markers in the CYP2C9, CYP2C19, CYP3A5, VKORC1, SLCO1B1 and TPMT pharmacogenes are concerned. Also, our data demonstrate notable differences in predicted genotype-based warfarin dosing among these populations. Our findings can be exploited not only to develop guidelines for medical prioritization, but most importantly to facilitate integration of pharmacogenomics and to support pre-emptive pharmacogenomic testing. This may subsequently contribute towards significant cost-savings in the overall healthcare expenditure in the participating countries, where pharmacogenomics implementation proves to be cost-effective